Finally, despite the significant antitumor effects of TBK1 inhibition demonstrated by in vitro culture systems and animal modeling, clinical benefit from the use of TBK1 inhibitors as cancer therapy was not observed with MMB and has yet to be investigated with AMX and others. The gene discussed is TBK1; the disease is cancer.